Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) FCF Margin (2019 - 2025)

Korro Bio (KRRO) has disclosed FCF Margin for 5 consecutive years, with 1592.11% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin changed N/A year-over-year to 1592.11%, compared with a TTM value of 952.92% through Sep 2025, changed N/A, and an annual FY2024 reading of 3433.55%, changed N/A over the prior year.
  • FCF Margin was 1592.11% for Q3 2025 at Korro Bio, down from 1326.58% in the prior quarter.
  • Across five years, FCF Margin topped out at 7465.49% in Q1 2023 and bottomed at 1592.11% in Q3 2025.
  • Average FCF Margin over 4 years is 346.62%, with a median of 586.24% recorded in 2021.
  • Peak annual rise in FCF Margin hit -4565bps in 2021, while the deepest fall reached -45262bps in 2021.
  • Year by year, FCF Margin stood at 176.72% in 2021, then surged by 4324bps to 7465.49% in 2023, then plummeted by -105bps to 393.97% in 2024, then tumbled by -304bps to 1592.11% in 2025.
  • Business Quant data shows FCF Margin for KRRO at 1592.11% in Q3 2025, 1326.58% in Q2 2025, and 963.57% in Q1 2025.